相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer
Angiolo Gadducci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
Ursula A. Matulonis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Mapping of DDR1 Distribution and Oligomerization on the Cell Surface by FRET Microscopy
Cosmin Mihai et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer
F. R. Hirsch et al.
ONCOGENE (2009)
Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1
Yasushi Shintani et al.
JOURNAL OF CELL BIOLOGY (2008)
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
Klarisa Rikova et al.
CELL (2007)
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib, reveal novel kinase and nonkinase targets
Uwe Rix et al.
BLOOD (2007)
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: A Gynecologic oncology group study
Robert A. Burger et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer
Edwin M. Posadas et al.
CANCER (2007)
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis
Gulisa Turashvili et al.
BMC CANCER (2007)
A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies
M. V. Seiden et al.
GYNECOLOGIC ONCOLOGY (2007)
Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1
Christian Hansen et al.
EXPERIMENTAL CELL RESEARCH (2006)
Identification of expressed genes characterizing long-term survival in malignant glioma patients
R. Yamanaka et al.
ONCOGENE (2006)
A gene atlas of the mouse and human protein-encoding transcriptomes
AI Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Overexpression of the cell adhesion molecules DDR1, claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer
VA Heinzelmann-Schwarz et al.
CLINICAL CANCER RESEARCH (2004)
p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop
PP Ongusaha et al.
EMBO JOURNAL (2003)
Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: A phase II trial of the Gynecologic Oncology Group
MA Bookman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Chemical inhibitors of protein kinases
AJ Bridges
CHEMICAL REVIEWS (2001)
Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development
WF Vogel et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair
GP Hou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons
RS Bhatt et al.
GENES & DEVELOPMENT (2000)
分享论文
